Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
drugs
Jul 24, 2024, 00:57 |
Blog
St. Baldrick's Foundation: Transforming Pediatric Cancer Research with Data for the Common Good
St. Baldrick's Foundation shared on LinkedIn: "The St. Baldrick's Foundation is proud to have supported…
Jul 23, 2024, 22:30 |
Blog
Hagop Kantarjian: The simultaneous combination of ponatinib and blinatumomab highly effective
Hagop Kantarjian shared on X: "The simultaneous combination of ponatinib and blinatumomab highly effective: MRD-negativity rate…
Jul 23, 2024, 15:52 |
Drugs
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
In the rapidly evolving field of oncology, we are witnessing remarkable advancements in various treatment…
Jul 21, 2024, 20:38 |
Blog
Pioneering Cancer Insights and Prevention Strategies - The Babak Lab
Maria Babak shared a post by The Babak Lab, on LinkedIn: "Don't miss out on these…
Jul 21, 2024, 16:25 |
Blog
A research project at Children's Cancer Institute that could lead to the first-ever effective drug to treat the deadly brain cancer
Children's Cancer Institute shared a post on LinkedIn: "A bold research project at Children's Cancer…
Jul 21, 2024, 10:33 |
Blog
Filippo Montemurro: RWE of drug-drug interactions on abemaciclib
Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X: "Clinical…
Jul 20, 2024, 21:26 |
Blog
David Fajgenbaum: Santa Claus theory of civilization
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared on…
Jul 20, 2024, 12:01 |
Blog
Join AstraZeneca Barcelona Hub's growing team
Michele Moschetta, Executive Director of Early Clinical Development Oncology at Barcelona AstraZeneca R and D…
Jul 19, 2024, 16:04 |
Blog
Attend the 2024 FDA Oncology Center of Excellence Pediatric Advocacy Forum
FDA Oncology shared on X: "Save the date and register to attend the 2024 FDA…
Jul 19, 2024, 14:41 |
Blog
DOR to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared a post on X: ''Durable Objective Response to Lurbinectedin in Small Cell…
28
29
30
31
32
All:
830
Posts:
291 - 300
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube